Circa Group AS engages in the production and sale of biochemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company extracts value from non-food waste biomass to produce bio-based chemicals through its Furacell production process. Its products include Cyrene, a polar aprotic solvent; and Levoglucosenone derivatives. The company's products are used in pharmaceuticals, agrochemicals, flavors, fragrances, electronics, batteries, paints, graphene, polymers, and other applications. Circa Group AS was founded in 2006 and is headquartered in Oslo, Norway.
Frequently asked questions
What sector does Circa Group AS (CIRCA) operate in?
Circa Group AS belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Circa Group AS (CIRCA) current stock price?
As of the latest data, Circa Group AS stock price is NOK 0.64, with a previous close of NOK 0.64.
What is Circa Group AS (CIRCA) current market capitalization?
Circa Group AS market cap is approximately 77.70 million.
What is Circa Group AS (CIRCA) Earnings Per Share (EPS)?
The trailing EPS is -NOK 0.70.
Does Circa Group AS (CIRCA) pay dividends?
No. Circa Group AS does not pay a dividend.
What is Circa Group AS (CIRCA) beta (volatility) score?
Circa Group AS has a beta of -0.098, indicating lower volatility than the overall market.
